Maintenance efficacy of divalproex in the prevention of bipolar depression (Q44464135)

3 December 2017

Maintenance efficacy of divalproex in the prevention of bipolar depression (English)

1 reference

3 December 2017

1 reference

4

Joseph R Calabrese

1 reference

3 December 2017

3

Susan L McElroy

1 reference

3 December 2017

12

Paul E Keck

1 reference

3 December 2017

11

Charles B Nemeroff

1 reference

3 December 2017

14

Patricia J Wozniak

1 reference

3 December 2017

Laszlo Gyulai

1

1 reference

3 December 2017

Charles L Bowden

2

1 reference

3 December 2017

Frederick Petty

5

1 reference

3 December 2017

Alan C Swann

6

1 reference

3 December 2017

James C-Y Chou

7

1 reference

3 December 2017

Adel Wassef

8

1 reference

3 December 2017

Craig S Risch

9

1 reference

3 December 2017

Robert M A Hirschfeld

10

1 reference

3 December 2017

Dwight L Evans

13

1 reference

3 December 2017

language of work or name

English

0 references

publication date

28 May 2003

1 reference

3 December 2017

Neuropsychopharmacology

1 reference

3 December 2017

28

1 reference

3 December 2017

7

1 reference

3 December 2017

1374-1382

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300190

3 December 2017

0 references

cites work

Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Clinical Factors in Lithium Carbonate Prophylaxis Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Current perspectives in the pharmacopsychiatry of depression and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Anxiety as a correlate of response to the acute treatment of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Relapse and impairment in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Maintenance treatment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Lithium response and genetics of affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Outcome in manic disorders. A naturalistic follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Long-term outcome of lithium prophylaxis in patients initially classified as complete responders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Outcome of bipolar disorder on long-term treatment with lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Mania: differential effects of previous depressive and manic episodes on response to treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300190

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300190

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference